WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021

Margaret A. Liu, Tiequn Zhou, Rebecca L. Sheets, Heidi Meyer, Ivana Knezevic

Open source

DOI
10.1080/22221751.2022.2026742
Published
2022-01-31
Container
Emerging Microbes & Infections
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/22221751.2022.2026742,
  title = {WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021},
  author = {Margaret A. Liu and Tiequn Zhou and Rebecca L. Sheets and Heidi Meyer and Ivana Knezevic},
  year = {2022},
  journal = {Emerging Microbes \& Infections},
  doi = {10.1080/22221751.2022.2026742},
  url = {https://doi.org/10.1080/22221751.2022.2026742}
}

RIS

TY  - JOUR
TI  - WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021
AU  - Margaret A. Liu
AU  - Tiequn Zhou
AU  - Rebecca L. Sheets
AU  - Heidi Meyer
AU  - Ivana Knezevic
PY  - 2022
JO  - Emerging Microbes & Infections
DO  - 10.1080/22221751.2022.2026742
UR  - https://doi.org/10.1080/22221751.2022.2026742
ER  - 

APA

Liu, M. A., Zhou, T., Sheets, R. L., Meyer, H., & Knezevic, I. (2022). WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2022.2026742

Source records